| MeSH term | MeSH ID | Detail |
|---|---|---|
| Toxoplasmosis, Ocular | D014126 | 2 associated lipids |
| Typhoid Fever | D014435 | 2 associated lipids |
| Acquired Hyperostosis Syndrome | D020083 | 1 associated lipids |
| Central Nervous System Protozoal Infections | D020808 | 3 associated lipids |
| Syncope, Vasovagal | D019462 | 1 associated lipids |
| Leishmaniasis, Mucocutaneous | D007897 | 1 associated lipids |
| Trichiasis | D058457 | 1 associated lipids |
| Paratyphoid Fever | D010284 | 1 associated lipids |
| Ectodermal Dysplasia | D004476 | 1 associated lipids |
| Tooth Erosion | D014077 | 2 associated lipids |
Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| See S | Is azithromycin monotherapy as efficacious as cefuroxime plus erythromycin for the treatment of community-acquired pneumonia in hospitalized patients? | 2000 | J Fam Pract | pmid:11052155 |
| Renz CL and Ashraf T | Comment: cost-effectiveness of macrolides in lower respiratory tract infections. | 2000 | Ann Pharmacother | pmid:11054992 |
| Boccazzi A et al. | Short course therapy with cefitbuten versus azithromycin in pediatric streptococcal pharyngitis. | 2000 | Pediatr. Infect. Dis. J. | pmid:11055597 |
| Bayoumi AM and Redelmeier DA | Decision analysis with cumulative prospect theory. | 2000 Oct-Dec | Med Decis Making | pmid:11059473 |
| Sader H and Del'Alamo L | Etest compared to broth microdilution: discrepant results when testing macrolides against Streptococcus pneumoniae indicate a need for better clinical and serum level/MIC correlation. | 2000 | Braz J Infect Dis | pmid:11063559 |
| Frenck RW et al. | Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. | 2000 | Clin. Infect. Dis. | pmid:11073741 |
| Dunne M et al. | A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus. | 2000 | Clin. Infect. Dis. | pmid:11073759 |
| Krause PJ et al. | Atovaquone and azithromycin for the treatment of babesiosis. | 2000 | N. Engl. J. Med. | pmid:11078770 |
| Macaigne G et al. | [Acute pseudoangiocholitic hepatitis probably induced by azithromycin]. | 2000 | Gastroenterol. Clin. Biol. | pmid:11084438 |
| Alvarez MP et al. | [Pharmacovigilance study of azithromycin tablets (500 mg) in the treatment of adult patients with respiratory tract infections]. | 2000 | Rev Esp Quimioter | pmid:11086281 |
| Gandhi R et al. | Validated LC method for in-vitro analysis of azithromycin using electrochemical detection. | 2000 | J Pharm Biomed Anal | pmid:11095310 |
| Bowman RJ et al. | Operational comparison of single-dose azithromycin and topical tetracycline for trachoma. | 2000 | Invest. Ophthalmol. Vis. Sci. | pmid:11095598 |
| Nagai K et al. | In vitro development of resistance to ceftriaxone, cefprozil and azithromycin in Streptococcus pneumoniae. | 2000 | J. Antimicrob. Chemother. | pmid:11102409 |
| Waterer GW et al. | Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy. | 2000 | Chest | pmid:11115489 |
| Esposito S and Ascione T | Short-course treatment for acute tonsillopharyngitis. | 2000 | Int. J. Antimicrob. Agents | pmid:11118866 |
| Rothstein NM et al. | Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae. | 2001 | J. Infect. Dis. | pmid:11120929 |
| Bermudez LE et al. | Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium. | 2001 | Antimicrob. Agents Chemother. | pmid:11120969 |
| Calabrese C et al. | Pantoprazole, azithromycin and tinidazole: short duration triple therapy for eradication of Helicobacter pylori infection. | 2000 | Aliment. Pharmacol. Ther. | pmid:11121909 |
| DeAbate CA et al. | The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis. | 2000 | Respir Med | pmid:11127487 |
| Fuchs PC et al. | Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin. | 2001 | J. Clin. Microbiol. | pmid:11136745 |